Home > Analytics > VIMTA LABS

VIMTA LABS
Intrinsic Value | Fundamental Analysis

BOM : 524394     NSE : VIMTALABS    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Apr 15,2024
Price(EOD): ₹ 459.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 1,019.20 Cr
Value of ₹ 1 Lac invested in VIMTA LABS
on Apr 15,2019 (price: ₹ 198.75)

₹ 1 L

₹ 2.31 L

1W : -2.5% 1M : -9.8% 1Y : 42%
COMMUNITY POLL
for VIMTA LABS
Please provide your vote to see the results
VIMTA LABS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
VIMTA LABS -2.5% -9.8% 42%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

FUNDAMENTAL ANALYSIS OF VIMTA LABS

 
Fundamentals Score
[ Q(TTM): Dec2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 VIMTALABS is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF VIMTA LABS

 
Valuation Score
[As on : Apr 15,2024 ]

Ratio Consolidated
P/E
P/B
P/S
24.62
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 41.34 Cr
[Latest Qtr - Dec2023 - Consolidated Results ]

3.7
P/B Calculated based on Book Value of Rs 275.43 Cr
[Latest Year - Mar2023 - Consolidated Results ]

3.18
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 320.39 Cr
[Latest Qtr - Dec2023 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 14% undervalued companies ! Discover More →

FAIR VALUE OF VIMTA LABS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
47%
64%
94%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF VIMTA LABS



VIMTA LABS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF VIMTA LABS

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0.05
0.08
0.15
0.09
0.05
0.08
0.16
0.1
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF VIMTA LABS

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF VIMTA LABS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
11.27%
37.49%
60.98%
60.11%
5.55%
1.79%
-4.08%
-1.06%
QtrlyTrend
4
Latest Qtr: Dec2023
Quarterly Result Analysis →


VIMTA LABS related INDICES

BSE Indices1W1M1Y
S&P BSE ALLCAP -1.2% 1% 39.4%
S&P BSE MIDSMALLCAP -1.6% 2.3% 63.6%
S&P BSE HEALTHCARE -1.9% -0.1% 56.2%
S&P BSE SMALL CAP -1.9% 3.2% 62.6%
No NSE index found

You may also like the below Video Courses


FAQ about VIMTA LABS


Is VIMTA LABS good for long term investment?

As on Apr 15,2024, the Fundamentals of VIMTA LABS look Strong and hence it may be good for long term investment! See Financial Performance of VIMTA LABS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is VIMTA LABS UnderValued or OverValued?

As on Apr 15,2024, VIMTA LABS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of VIMTA LABS ?

As on Apr 15,2024, the Intrinsic Value of VIMTA LABS is Rs. 279.61 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 312.90
Fair Value [Median EV / Sales Model] : Rs. 279.61
Fair Value [Median Price / Sales Model] : Rs. 236.81
Estimated Median Fair Value of VIMTA LABS : Rs. 279.61

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is VIMTA LABS trading at a Premium or Discount?

As on Apr 15,2024, VIMTA LABS is trading at a Premium of 64% based on the estimates of Median Intrinsic Value!